Member Info for Keving23

I really hope so

He is most probably meaning if it stays above £8.

I am personally really wanting it to start moving above £10+

It means how long it will take to buy the shares back for covering the short sells

I am really hoping for what happened the day of that announcement lol wishful thinking, jumping from 4p old (£16 new) to 7p old (£28 new).

It was jumping around all over the place, no one was able to trade, then a RNS announcement and then price plummeted.

I pray to God that doesn't happen again 🙏 😕 😪

The reverse share stock split was 1 new share to 400 old shares ???? It doesn't how much they have diluted the share price since, it still stands at that ratio?? Yes or no

What are you going on about 1p = £4 new money, there is no if our buts about it.

4p old money = £16 new, I am really hoping we get to £16 today , pre approval for clinical phase 1 trials

Https://www.marketwatch.com/investing/stock/hophf

And before you ask what the ticker code is, its HOPHF

The most obvious reason why they did the reverse share price split is that USA institutional investors can't invest in penny stocks (USA) market under $5.

This company is also traded on the USA market but with a different ticker code.

I am really sorry I missed typed 100:1 for 400:1 lol

But if you look at my my calculations they are correct??

The share price jumped to 7p a share just after the phase 1 trials approval?? Yes or no

That means in today's money the shareprice would be £28??

7p × 400 = ??

I just looked at my account balance and it says I am now only 2.82% down from my investment at the sell price 510.

Happy days if carries on, but it would need to jump to £28 to get to what it was just before it plummeted, I know it was only at that price for minutes before it dropped, straight after the phase 1 approval

I have been invested in this company for years now and it was well before the 1:100 Reverse Stock Split.

I hope they keep doing well and keep up the good 'progress they are making.

nevertheless this stock is still trading well below its market value prior to its clinical phase 1 approval announcement.

From what i can remember the stock was trading like 1.5p and jumped to around about 4p just before the announcement and then afterwards its started jumping all over the place to like 7p for minutes and then crashed.

And Then there was some leaky news days before the rns when the share price plummeted.

I do hope its the other way around this time and I can finally get my money back with a nice profit

This is the link https://www.tipranks.com/news/company-announcements/hemogenyx-pharmaceuticals-secures-funding-for-clinical-trials-2

Hemogenyx Pharmaceuticals Secures Funding for Clinical Trials

Story Highlights

Hemogenyx raised £451,250 for Phase 1 trials of HG-CT-1.

Funding reflects confidence in Hemogenyx’s long-term potential.

Looking for the best stocks to buy? .

Hemogenyx Pharmaceuticals Secures Funding for Clinical Trials

Around the Web

Revcontent

and never miss an update about DE:5HU0 stock!

Confident Investing Starts Here:

Easily unpack a company's performance for smart investment decisions

Receive undervalued, market resilient stocks right to your inbox

The latest announcement is out from HemoGenyx Pharmaceuticals Plc ( ).

Hemogenyx Pharmaceuticals has raised £451,250 to continue its Phase 1 clinical trials for its Chimeric Antigen Receptor T-cell therapy, HG-CT-1, targeting relapsed/refractory acute myeloid leukemia in adults. This funding, secured at a premium, reflects investor confidence in the company’s long-term potential and allows the advancement of their pivotal therapy without significant dilution, potentially strengthening their position in the biopharmaceutical industry.

More about HemoGenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals is a publicly traded clinical stage biopharmaceutical company based in London, with US subsidiaries in New York City. The company focuses on developing new medicines and treatments for blood and autoimmune diseases, leveraging platform technologies for novel product development.

Average Trading Volume: 40,185

Technical Sentiment Signal: Sell

Current Market Cap: £7.59M

Find detailed analytics on HEMO stock on

Even if they can't release the results of that well, they must be still be able to say they have moved to the new site, with a new start date?

Without reading the RNS again doesn't it say, once the drilling is completed and tested, they would be moving onto the next site that should be only a few miles away.

How can they do that without releasing the test results 1st?

Don't you mean 0.10p, if it jumps to 1p the marketcap would be @ around £168 million from the current £8.74 million it is at the moment

I am 98% down on my he1 investment from years ago, so I am not really a good fan of this company, also sarah cope was also on AAOG that I lost 100% of my money

If you look at blue star share price, they jumped 16% on close, but if you look how much money they have in the bank, I very much doubt they would be able to afford to buy the well off of msmn because it doesn't look like they have much cash in the bank

There is no way they are going to release the results before the retail share offer closes today at 4pm